What is the workup and treatment for a urinary tract infection (UTI) associated with a double J (DJ) stent?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of UTI Associated with DJ Stent

For UTIs associated with double J (DJ) ureteral stents, obtain urine culture before starting empirical broad-spectrum antibiotic therapy against Enterobacteriaceae and Enterococci, and adjust treatment based on culture results. 1

Diagnostic Workup

  • CT urography with both nephrographic and excretory phases is the gold standard diagnostic exam for suspected urinary tract complications related to DJ stents 1
  • Obtain urine culture before initiating antibiotics to guide targeted therapy 1, 2
  • Serum inflammatory markers (e.g., C-reactive protein), renal function tests, and peritoneal fluid analysis (if applicable) may be useful diagnostic tools when CT urography is unavailable 1
  • Consider stent culture at removal, as stent colonization can occur even with negative urine cultures 3, 4

Microbiology Considerations

  • The most common pathogens in DJ stent-associated UTIs are Escherichia coli, Enterococcus species, Staphylococcus species, Pseudomonas, and Candida species 3, 5
  • Bacterial colonization of DJ stents increases significantly with indwelling time - from 2.2% when in place <4 weeks to 25% when in place >6 weeks 6
  • Stent isolates often show higher antibiotic resistance compared to organisms isolated before stent insertion 3

Treatment Approach

Empiric Antibiotic Therapy

  • Start empirical broad-spectrum antibiotic therapy as soon as possible in patients with signs of infection, sepsis, or septic shock 1
  • For complicated UTIs with systemic symptoms, consider:
    • Third-generation cephalosporins (e.g., ceftriaxone 1-2g daily) 2
    • Fluoroquinolones (e.g., ciprofloxacin 500-750mg twice daily) if local resistance rates are below 10% 2, 7
    • Aminoglycosides for severe infections or suspected resistant organisms 2, 3

Treatment Duration

  • Short-course antibiotic therapy (3-5 days) is recommended in cases with adequate source control 1
  • For complicated UTIs, 7-14 days of treatment may be necessary, with early re-evaluation based on clinical course and laboratory parameters 2

Source Control

  • Consider stent removal or replacement if infection persists despite appropriate antibiotic therapy 3, 8
  • If the stent has been in place for ≥2 weeks when UTI is diagnosed, replacing it before initiating antibiotics may improve outcomes 2

Special Considerations

  • Adjust antibiotic dose and timing based on patient's weight, renal clearance, and liver function 1
  • Empirical antifungal therapy is not recommended for stent-associated UTIs unless fungal infection is documented 1
  • In patients with diabetes mellitus, chronic renal failure, or diabetic nephropathy, there is a higher risk of bacteriuria with DJ stents (57-78% vs. 28% in patients without these conditions) 3

Prevention Strategies

  • Antibiotic prophylaxis at the time of stent insertion may reduce the risk of subsequent UTI (8.1% UTI rate without prophylaxis vs. 1.4% with prophylaxis) 8
  • Consider norfloxacin or ciprofloxacin as prophylaxis prior to stent insertion 3
  • Minimize stent dwell time when possible, as bacterial colonization increases significantly after 6 weeks 5, 6

Common Pitfalls to Avoid

  • Failing to obtain urine culture before starting antibiotics 2
  • Using fluoroquinolones empirically when local resistance rates are high 2
  • Inadequate treatment duration, especially in complicated infections 2
  • Not replacing long-term catheters before initiating treatment 2
  • Relying solely on urine culture to rule out stent colonization (60% of patients with positive stent cultures may have sterile urine) 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Klebsiella Urinary Tract Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Bacterial colonization of double J stents and bacteriuria frequency.

The Kaohsiung journal of medical sciences, 2013

Research

Urinary tract infection and antibiotic use around ureteral stent insertion for urolithiasis.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.